project id: TCGA-COAD; case submitter id: TCGA-A6-6782; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; age at index: 82; days to birth: -30012; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1929; age at diagnosis: 30012; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T4a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 617.0; icd 10 code: C18.2; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Ascending colon; synchronous malignancy: No; tissue or organ of origin: Ascending colon; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; intermediate dimension: 0.9; longest dimension: 1.7; preservation method: Unknown; shortest dimension: 0.9; sample id: 844a005f-471c-45d5-86de-956951d6b7d1; sample submitter id: TCGA-A6-6782-01A; portion id: 92afc0fe-a7d0-4890-a131-b6062f175879; portion submitter id: TCGA-A6-6782-01A-11; percent monocyte infiltration: 1.0; percent necrosis: 1.0; percent neutrophil infiltration: 1.0; percent normal cells: 0.0;